Trends in Medicare Costs of Hyperbaric Oxygen Therapy, 2013 through 2022 | Canada Hyperbarics Skip to main content
Study Undersea Hyperb Med 2024

Trends in Medicare Costs of Hyperbaric Oxygen Therapy, 2013 through 2022

Gelly H, Fife C, Walker D, Eckert K — Undersea Hyperb Med, 2024

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers analyzed a US registry of 53 HBOT centres from 2013 to 2022 to calculate the actual Medicare cost of HBOT per patient and per treatment course, adjusted for inflation.

What They Found

The total cost for a standard 40-session HBOT course decreased by 15.6%, from $27,562 in 2013 to $23,834 in 2022. A single HBOT session cost $595.86 in 2022. Physician fees dropped 37.8% over this period. Costs for different conditions ranged from about $2,383 for crush injuries to $35,752 for diabetic foot ulcers requiring a full course.

Canadian Relevance

No direct Canadian connection identified. In Ontario, HBOT for diabetic foot ulcers and delayed radiation injuries is OHIP-covered, so Canadian patients with those conditions should not face out-of-pocket costs at eligible facilities.

Study Limitations

US Medicare reimbursement rates do not directly translate to Canadian public or private HBOT pricing.

Was this summary helpful?

Study Details

Study Type Study
Category Uncategorised
Source Pubmed
PubMed ID 38985150
Year Published 2024
Journal Undersea Hyperb Med
MeSH Terms Hyperbaric Oxygenation; Humans; Medicare; United States; Registries; Health Care Costs

Cite This Study

Share

Find a Canadian Clinic Treating Uncategorised

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.